Trial to Assess the Effect of Long Term Dosing of Inclisiran in Subjects With High CV Risk and Elevated LDL-C

NCT03814187 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3275

Enrollment

INDUSTRY

Sponsor class

Conditions

ASCVD
Elevated Cholesterol
Heterozygous Familial Hypercholesterolemia
Homozygous Familial Hypercholesterolemia

Interventions

DRUG: Inclisiran Sodium

Sponsor

Novartis Pharmaceuticals